X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/pierre-fabre-pharmaceuticals-inc-announces-the-fda-acceptance-and-priority-review-of-the-biologics-license-application-for-tabelecleucel-tab-cel-for-the-treatment-of-epstein-barr-virus-positive-post-transplant-lymphoproliferat-302200702.html
https://www.prnewswire.com/news-releases/pierre-fabre-laboratories-announce-granting-of-european-marketing-authorization-for-obgemsa-vibegron-in-overactive-bladder-302185906.html
https://www.prnewswire.com/news-releases/pierre-fabre-laboratories-announce-granting-of-european-marketing-authorization-for-obgemsa-vibegron-in-overactive-bladder-302185906.html
https://www.ema.europa.eu/en/documents/overview/obgemsa-epar-medicine-overview_en.pdf
https://www.pierre-fabre.com/en/press_release/green-bioplastics-project-wins-1st-prize-in-the-maud-fontenoy-foundation
https://www.prnewswire.com/news-releases/pierre-fabre-laboratories-announce-ind-filing-for-pfl-002vert-002-a-potential-treatment-for-patients-with-solid-tumors-including-non-small-cell-lung-cancer-with-met-alterations-302163756.html
https://www.pierre-fabre.com/en/press_release/pierre-fabre-laboratories-awarded-responsible-digital-label
https://www.prnewswire.com/news-releases/pierre-fabre-laboratories-receive-positive-chmp-opinion-for-obgemsavibegron-in-overactive-bladder-syndrome-302128768.html
https://www.contractpharma.com/contents/view_breaking-news/2024-04-04/pierre-fabre-appoints-adriana-herrera-ceo-of-new-us-affiliate/
https://www.pierre-fabre.com/en/press_release/global-study-on-rosacea-5-of-the-population-affected-according-to-pierre-fabre
Market Place
Share 
